You Asked for It. We Organized It.

By R. Lewis Dark | From the Volume XXIX, No. 12 – August 29, 2022 Issue

DESPITE THE EASING OF THE COVID-19 PANDEMIC IN RECENT MONTHS, a pre-pandemic normal does not yet exist—if it ever will. Currently, most clinical laboratories, particularly those serving hospitals and health systems, are under the most intense pressure seen in decades….

Read More

---

News and Insights from AACC Meeting in Chicago

By Robert Michel | From the Volume XXIX, No. 11 – August 8, 2022 Issue

CEO SUMMARY: There was plenty of positive energy last month when the 72nd Annual Scientific Meeting and Exhibition of the American Association of Clinical Chemistry (AACC) took place in Chicago. Attendees seemed pleased to be gathering and networking in person. However, there was re…

Read More

---

New Trends Reshaping Healthcare, Lab Testing

By Robert Michel | From the Volume XXIX, No. 4 – March 14, 2022 Issue

…

Read More

---

February 22, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue

Scopio Labs, a medical imaging company in Tel Aviv, recently landed $50 million in Series C venture capital funding as it moves to more fully enter the clinical laboratory market, TechCrunch reported on Feb. 9. Scopio has developed a scanner that can magnify a whole blood sample by 100 …

Read More

---

Congress Votes: No PAMA Price Cuts for 2022

By R. Lewis Dark | From the Volume XXVIII, No. 17 – December 20, 2021 Issue

IT’S WELCOME NEWS THAT CONGRESS VOTED EARLIER THIS MONTH to defer the PAMA price cuts to the Clinical Laboratory Fee Schedule (CLFS) that were scheduled to take place in 2022. This is a positive development for the finances of the nation’s clinical labs, particularly the smaller, independent labs t…

Read More

---

December 20, 2021 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXVIII, No. 17 – December 20, 2021 Issue

In Europe, Switzerland-based Unilabs will be acquired by a Danish company. Unilabs owns laboratories in at least 11 European countries and posted revenue of €2 billion euros (US $2.26 billion) in the financial year ending September. The seller is Apax Partners, a private equity compan…

Read More

---

Many Patients in United Kingdom Not Getting Speedy Diagnosis

By Robert Michel | From the Volume XXVIII, No. 11 – August 16, 2021 Issue

RECENT NEWS REPORTS IN THE UNITED KINGDOM indicate that the COVID-19 pandemic has exacerbated the ongoing problem of lengthy delays in diagnosis of patients within the National Health Service (NHS). This is particularly true of delays for patients waiting on results of their cancer tests….

Read More

---

Pandemic Complicates Sales for Lab Info System Companies

By Robert Michel

HEALTHCARE INFORMATION TECHNOLOGY (IT) COMPANIES serving clinical laboratories and providers with laboratory information systems (LISs) and electronic health records (EHRs) shared recent financial reports on their businesses.  It is challenging to obtai…

Read More

---

What Comes Next? Predictions on COVID-19 Test Volumes in 2021-22

By Robert Michel | From the Volume XXVIII, No. 4 – March 22, 2021 Issue

CEO SUMMARY: Incoming data show that the number of referrals for both COVID-19 tests and routine tests is in a decline that started in October and is continuing. This complicates the strategic planning for hospital/health system labs, independent labs, and pathology groups. They nee…

Read More

---

COVID-19 Variant Sequencing Offers Clinical Opportunities

By Robert Michel | From the Volume XXVIII No. 3 – March 1, 2021 Issue

This is an excerpt of a 2,987-word article in the March 1, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In Wisconsin, an oncology research lab started sequencing variants of the SARS-CoV-2 virus and fou…

Read More

---